Institute of Cellular Medicine

Staff Profile

Dr Olivier Govaere

Research Associate

Background

About

Dr. Olivier Govaere is a research associate based at the Institute of Cellular Medicine, Newcastle University. He obtained his Master in Biomedical Sciences at the KU Leuven, Belgium. In 2008 he joined the lab of Prof. Dr. Tania Roskams to do a PhD focusing on the role of hepatic progenitor cells in liver regeneration and carcinogenesis.  He continued his work at the lab of Prof. Dr. Tania Roskams during a 3-year postdoctoral fellowship investigating phenotype switching in human hepatocellular carcinomas and characterisation of the human hepatic progenitor cell niche in chronic liver disease.

Dr. Govaere joined the Newcastle liver group to work on the EPOS project (Elucidating Pathways of Steatohepatitis) with Prof. Quentin Anstee, Prof. Ann Daley and Prof. Fiona Oakley.

EPoS: Elucidating Pathways of Steatohepatitis is funded by the EU Horizon 2020 scheme. This consortium focuses on understanding the pathophysiology of NAFLD and examining the determinants of individual risk for disease progression using a "multi-omics" translational-science approach. 

Education

  • BSc, KULeuven, Belgium (2006)
  • MSc, KULeuven, Belgium (2008)
  • PhD in Molecular and Stem Cell Medicine, KU Leuven, Belgium (2012)
  • Certificate in ‘Knowledge & technology transfer and the exploitation of research’, KU Leuven Research & Development (2014) 


Memberships of Learned Societies

  • European Association for the Study of the Liver (EASL)


Esteem Indicators


Peer Review activities

  • International journals including “Gut”, “Journal of Hepatology”, “British Journal of Cancer”, “Oncotarget”, “Theranostics”.
  • Grant awarding bodies including Research Grants Council of Hong Kong.

Selected Invited Lectures and oral presentation at international meetings

 

  • Practicalities of ‘Omics. Scientific Facilities Conference 2018, Newcastle upon Tyne, UK.
    “A high-throughput RNA sequencing approach to elucidate pathways of steatohepatitis”
  • Annual meeting of the European Association for the Study of the Liver (EASL), Amsterdam, The Netherlands, 2017
    “High-throughput RNA sequencing unravels pathways associated with the progression of non-alcoholic fatty liver disease “
  • 5th European Young Hepatologists Workshop, Marseille, France 2015
    “Hepatic progenitor cells in chronic liver disease”
  • Belgian Week of Gastroenterology, Brussels, Belgium, 2015
    Young BASL. Lab introduction: Translational Cell and Tissue Research, Department of Imaging & Pathology.
  • Annual meeting of the European Association for the Study of the Liver (EASL), Vienna, Austria, 2015
    “High-throughput sequencing of the human hepatic progenitor cell niche reveals different signalling pathways depending on the underlying chronic liver disease.”
  • EASL HCC Summit Geneva, Switzerland, 2014
    “Side Population analysis identifies a role for laminin in modulating the human hepatic cancer stem cell niche.”
  • Annual meeting of the European Association for the Study of the Liver (EASL), Amsterdam, 2013
    “EASL - Young Investigator’s Seminar: IS CELL THERAPY THE FUTURE FOR LIVER DISEASE TREATMENT? 
  • ICR-Lecture Series. Institute of Cancer Research, Medical University Vienna, Austria. 2013.
    “Hepatic progenitor cells and their role in cancer.”
  • Annual meeting of the European Association for the Study of the Liver (EASL), Barcelona, Spain, 2012
    “Keratin19: A Key Role Player in the Invasion of Human Hepatocellular Carcinomas with Progenitor Cell Features.” 

Awards

  • Award for Best Clinical Presentation, Belgian Week of Gastroenterology, 2011
  • Award for Best Abstract, 6th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 2011
  • F1000Prime. Faculty of 1000 Recommendation for ‘Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. Gut, 2013 (DOI: 10.3410/f.718078724.793486745)’
  • Young Investigator Top 10% award, EASL, London, 2014. Abstract “Side Population analysis identifies a role for laminin in modulating the human hepatic cancer stem cell niche.”
  • MSD award Best Clinical Publication: ‘Keratin19: A Key Role Player in the Invasion of Human Hepatocellular Carcinomas’. BASL Winter Meeting, La Hulpe, Belgium 2014.
  • EASL Young Investigator Bursary, Annual meeting of the European Association for the Study of the Liver 2011, 2012, 2013, 2014 and 2015.
  • Inter-university initiative within the ‘Framework for Young Researchers’ (OJO) from the Flemish government, to finance the ‘young BASL School of Hepatology 2015’.
  • Award for best oral presentation, 5th European Young Hepatologists Workshop, Marseille, France 2015.
  • NUSCU project award 2017. 
Google scholar: Click here.

Publications